Inspiration FACTOR @Google: alpha‑bet (Alpha is investment return above benchmark), which we strive for!
Reporter: Aviva Lev-Ari, PhD, RN
NATURE | NEWS
Why biomedical superstars are signing on with Google
Tech firm’s ambitious goals and abundant resources attract life scientists.
Getting stuff done was foremost in the mind of electrical engineer Brian Otis when he left his tenured position at the University of Washington in Seattle in 2012 to work for Google. He went there to work on a ‘smart’ contact lens for people with diabetes that measures the level of glucose in tears. When the project began, it faced two big questions: first, could the electronics needed to make a functional wireless glucose sensor be embedded in a wearable contact lens? And second, would it provide the relevant measurements of glucose levels? The motivation and means to answer those unknowns was a powerful incentive, Otis says. He recalls thinking: “If I come into Google life with these questions, I have the entire runway and resources to answer these two questions.”
SOURCE
This story appeared in print under the headline “Tech titans lure life-sciences elite”.
As Sergey and I wrote in the original founders letter 11 years ago, “Google is not a conventional company. We do not intend to become one.”
We did a lot of things that seemed crazy at the time. Many of those crazy things now have over a billion users, like Google Maps, YouTube, Chrome, and Android. And we haven’t stopped there. We are still trying to do things other people think are crazy but we are super excited about.
We’ve long believed that over time companies tend to get comfortable doing the same thing, just making incremental changes. But in the technology industry, where revolutionary ideas drive the next big growth areas, you need to be a bit uncomfortable to stay relevant.
We are excited about…
- Getting more ambitious things done.
- Taking the long-term view.
- Empowering great entrepreneurs and companies to flourish.
- Investing at the scale of the opportunities and resources we see.
- Improving the transparency and oversight of what we’re doing.
- Making Google even better through greater focus.
- And hopefully… as a result of all this, improving the lives of as many people as we can.
What could be better? No wonder we are excited to get to work with everyone in the Alphabet family. Don’t worry, we’re still getting used to the name too!
READ MORE from the SOURCE
2012pharmaceutical
Amandeep Kaur
Aashir Awan, Phd
Abhisar Anand
Adina Hazan
Alan F. Kaul, PharmD., MS, MBA, FCCP
alexcrystal6
anamikasarkar
apreconasia
aviralvatsa
David Orchard-Webb, PhD
danutdaagmailcom
Demet Sag, Ph.D., CRA, GCP
Dror Nir
dsmolyar
Ethan Coomber
evelinacohn
FrasonKalapurackal
Gail S Thornton
Irina Robu
jayzmit48
jdpmd
jshertok
kellyperlman
Ed Kislauskis
larryhbern
Madison Davis
marzankhan
megbaker58
ofermar2020
Dr. Pati
pkandala
ritusaxena
Rick Mandahl
sjwilliamspa
Srinivas Sriram
stuartlpbi
Dr. Sudipta Saha
tildabarliya
zraviv06
zs22
Leave a Reply